Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Pierre Meulien"'
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionInnovative medicines and vaccines can provide direct health benefits to patients and populations by preventing, treating and curing diseases, and also drive wider socioeconomic and productivity gains. However, researching and developing t
Externí odkaz:
https://doaj.org/article/ed97453fe4a64c2389d9a49f797198e9
Autor:
Hugh Laverty, Pierre Meulien
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. Born of the necessity to foster collaboration between different stakeholders in order to address growing ch
Externí odkaz:
https://doaj.org/article/0fe31c777285464c9cd557071bc12396
Autor:
Pierre Meulien, Andrea Pavirani
Publikováno v:
Factor VIII—von Willebrand Factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e61a5e6eb02a76bb2265f1235e922d51
https://doi.org/10.1201/9781003210443-2
https://doi.org/10.1201/9781003210443-2
Autor:
Pierre Meulien, Hugh Laverty
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Frontiers in Medicine
Frontiers in Medicine
The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. Born of the necessity to foster collaboration between different stakeholders in order to address growing ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8ed338d67b0e5ed882621f02b67b965
https://www.frontiersin.org/article/10.3389/fmed.2019.00275/full
https://www.frontiersin.org/article/10.3389/fmed.2019.00275/full
Autor:
Pierre, Meulien
Publikováno v:
Studies in health technology and informatics. 258
IMI is a large public private partnership which has committed Euro 5 Billion from the European Commission, the European Pharmaceutical sector and other partners, to enable and accelerate bringing medical innovation to patients. IMI is now 10 years ol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::797aebcce06ddef5e1cc1e01a508b555
https://pubmed.ncbi.nlm.nih.gov/30942701
https://pubmed.ncbi.nlm.nih.gov/30942701
Autor:
Pierre Meulien
Publikováno v:
Nature Microbiology. 6:137-137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6128ca0200b3dd25e0fbfb9ca764176
https://doi.org/10.1038/s41564-020-00862-z
https://doi.org/10.1038/s41564-020-00862-z
Autor:
Georges De Moor, Veli N. Stroetmann, Terje Peetso, Petra Wilson, Bart Vannieuwenhuyse, Mary Baker, Mats Sundgren, Peter Singleton, John O’Brien, Pascal Coorevits, Dipak Kalra, Pierre Meulien, Brecht Claerhout
Publikováno v:
Journal of Medicines Development Sciences. 4:1
The European Institute for Innovation through Health Data (i~HD) has been formed as one of the sustainable entities arising from the Electronic Health Records for Clinical Research (EHR4CR) and SemanticHealthNet projects, in collaboration with other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74b04e11ad4f93b4f549dc98d2f91f2
https://doi.org/10.18063/jmds.v2i2.165
https://doi.org/10.18063/jmds.v2i2.165
Autor:
Pierre Meulien
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :OS-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a313c95c62d7f903aa9290e5d6eb33e2
https://doi.org/10.1254/jpssuppl.wcp2018.0_os-3
https://doi.org/10.1254/jpssuppl.wcp2018.0_os-3
Autor:
Isabelle Buchet, Marc B. Blumen, Chantal Hausser Hauw, Frédéric Chabolle, Pierre Meulien, Helene Neveu
Publikováno v:
Otolaryngology–Head and Neck Surgery. 141:591-597
Objective To evaluate adverse effects/postoperative complications and surgical response rate of maxillomandibular advancement for the treatment of severe obstructive sleep apnea syndrome. Study Design Case series with chart review. Setting Otolaryngo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc725d1e8a5b38c823794a6c4d66c05
https://doi.org/10.1016/j.otohns.2009.08.025
https://doi.org/10.1016/j.otohns.2009.08.025
Autor:
Yves Girerd-Chambaz, Annabelle Bonnin, Cécile Verdelet, Violette Sanchez, Emanuelle Trannoy, Pierre Meulien, Jean Haensler, Shiv Krishnan
Publikováno v:
Vaccine. 17:628-638
We have used spring powered jet injectors to deliver a solution of a naked DNA vaccine encoding the influenza hemagglutinin HA into the skin of mice and monkeys. We compared the immune responses induced by this needleless injection technique into the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de413b1d17af0f81e7a1b9ab59b1253
https://doi.org/10.1016/s0264-410x(98)00242-4
https://doi.org/10.1016/s0264-410x(98)00242-4